Cite
HARVARD Citation
Lightner, A. et al. (n.d.). P427 One Year Follow up of Three Phase IB/IIA Clinical Trials of Ex Vivo Expanded Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulizing Crohn's Disease. Journal of Crohn's and colitis. pp. i555-i556. [Online].